Key facts
- This page summarizes Robert Doran's Form 3 filing for BIOREGENX, INC. (BRGX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Apr 2024, 12:54.
Robert Doran - 08 Mar 2024 Form 3 Insider Report for BIOREGENX, INC. (BRGX)
- Reporting relationship
- Executive Vice President, Director, 10%+ Owner
- Issuer ticker
- BRGX
- Reported as of
- 08 Mar 2024
- Net transaction value
- $0
- Reporting owner signature
- Robert Doran
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Robert Doran filed Form 3 for BIOREGENX, INC. (BRGX) on 24 Apr 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FDIT
holding
Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 73,840,300
- Date
- 08 Mar 2024
- Ownership
- Trustee of JARA Trust
FDIT
holding
Series A Preferred
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 400
- Date
- 08 Mar 2024
- Ownership
- Trustee of JARA Trust
* marks a reported price that did not pass the local price check.